<SEC-DOCUMENT>0000921895-23-001857.txt : 20230914
<SEC-HEADER>0000921895-23-001857.hdr.sgml : 20230914
<ACCEPTANCE-DATETIME>20230809161918
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000921895-23-001857
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230809

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HARVARD BIOSCIENCE INC
		CENTRAL INDEX KEY:			0001123494
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043306140
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		84 OCTOBER HILL RD
		CITY:			HOLLISTON
		STATE:			MA
		ZIP:			01746
		BUSINESS PHONE:		5088938999

	MAIL ADDRESS:	
		STREET 1:		84 OCTOBER HILL ROAD
		CITY:			HOLLISTON
		STATE:			MA
		ZIP:			01746
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="image_001.jpg" ALT="Logo&#10;&#10;Description automatically generated" STYLE="height: 73px; width: 239px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">August 9, 2023</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><U>VIA EDGAR</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">United States Securities and Exchange Commission<BR>
Division of Corporation Finance<BR>
Disclosure Review Program<BR>
100 F Street, N.E.<BR>
Washington, D.C. 20549<BR>
Attention: Cheryl Brown and Amanda Ravitz</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">Re:</TD><TD STYLE="text-align: justify">Harvard Bioscience, Inc.<BR>
Definitive Proxy Statement on Schedule 14A<BR>
Filed April 5, 2023<BR>
File No. 001-33957</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt">Dear Ms. Brown and Ms. Ravitz:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">We acknowledge receipt
of the letter of comment dated July 28, 2023 from the staff (the &ldquo;Staff&rdquo;) of the Securities and Exchange Commission with regard
to the Definitive Proxy Statement on Schedule 14A filed by Harvard Bioscience, Inc. (the &ldquo;Company&rdquo;) on April 5, 2023 (the
 &ldquo;DEF 14A&rdquo;). Capitalized terms used herein and not separately defined have the meanings given to them in the DEF 14A. To facilitate
the Staff&rsquo;s review, we have reproduced the text of the Staff&rsquo;s comment in italics below, and our response appears immediately
below the comment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><U>Definitive Proxy Statement on Schedule 14A filed April 5, 2023</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt"><U>Pay versus Performance, page 25</U></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><I>1.</I></TD><TD STYLE="text-align: justify"><I>Refer to the pay versus performance table. We note that the amounts listed for 2021 and 2022 in column
(b) are not the same as the amounts listed for those years in the PEO &ldquo;TOTAL&rdquo; column of the Summary Compensation Table on
page 20. Similarly, the average of the non-PEO NEO amounts reported in column (d) do not appear to be consistent with the amounts reported
in the &ldquo;TOTAL&rdquo; column of the Summary Compensation Table for the non-PEO NEOs. Please ensure that you have entered the correct
Summary Compensation Table amounts in your pay versus performance tables pursuant to Regulation S-K Item 402(v) and that the calculation
of compensation actually paid and your relationship disclosures reflect the appropriate calculations.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Company will ensure
that it enters the correct Summary Compensation Table amounts in future pay versus performance tables pursuant to Regulation S-K Item
402(v) and that the calculation of compensation actually paid and the relationship disclosures reflect the appropriate calculations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">* * * * *</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">August 9, 2023</P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">Page <!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --></P><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0.5in">The Staff is invited to
contact the undersigned with any comments or questions it may have. We would appreciate your prompt advice as to whether the Staff has
any further comments.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-size: 10pt; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">Sincerely,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; border-bottom: Black 0.5pt solid">/s/ John Fry</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">John Fry</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Legal Counsel and Secretary</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Harvard Bioscience, Inc.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !) .\# 2(  A$! Q$!_\0
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M"]2>"?0?K6EXT\)#Q+9QR0.L=[!GRRW1@?X3_0_XT[I,5FT=/&B11K'&H5%
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"_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
